FDA approves Bristol Myers Squibb’s Subcutaneous Opdivo Qvantig™ for various solid tumor indications
December 2024- Bristol Myers Squibb announced that the U.S. Food and Drug…
Search
Have an existing account?
Sign In
Tag: Opdivo Qvantig™